Erste Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Hold	73,100	–	–	0.01%	396
2025 Q4	$2.09M	Hold	73,100	–	–	0.02%	347
2025 Q3	$1.36M	Hold	73,100	–	–	0.01%	385
2025 Q2	$1M	Hold	73,100	–	–	0.01%	505
2025 Q1	$1.15M	Hold	73,100	–	–	0.01%	362
2024 Q4	$1.05M	Buy	73,100 +62,000	+559%	+$679K	0.01%	381
2024 Q3	$104K	Hold	11,100	–	–	﹤0.01%	493
2024 Q2	$105K	Hold	11,100	–	–	﹤0.01%	490
2024 Q1	$106K	Hold	11,100	–	–	﹤0.01%	489
2023 Q4	$36.6K	Hold	11,100	–	–	﹤0.01%	516
2023 Q3	$61.5K	Hold	11,100	–	–	﹤0.01%	509
2023 Q2	$92.5K	Hold	11,100	–	–	﹤0.01%	520
2023 Q1	$121K	Hold	11,100	–	–	﹤0.01%	524
2022 Q4	$162K	Hold	11,100	–	–	﹤0.01%	517
2022 Q3	$207K	Hold	11,100	–	–	﹤0.01%	496
2022 Q2	$246K	Hold	11,100	–	–	0.01%	496
2022 Q1	$208K	Hold	11,100	–	–	﹤0.01%	503
2021 Q4	$227K	Hold	11,100	–	–	﹤0.01%	486
2021 Q3	$251K	Hold	11,100	–	–	0.01%	463
2021 Q2	$287K	Hold	11,100	–	–	0.01%	455
2021 Q1	$299K	Buy	+11,100	New	+$347K	0.01%	427